DNA polymorphism analysis of candidate genes for type 2 diabetes mellitus in a Mexican ethnic group.
Type 2 diabetes mellitus is a complex metabolic disorder resulting from the action and interaction of many genetic and environmental factors. It has been reported that polymorphisms in genes involved in the metabolism of glucose are associated with the susceptibility to develop type 2 diabetes mellitus. Although the risk of developing type 2 diabetes mellitus increases with age, as well as with obesity and hypertension, its prevalence and incidence are different among geographical regions and ethnic groups. In Mexico, a higher prevalence and incidence has been described in the south of the country, and differences between urban and rural communities have been observed. We studied 73 individuals from Santiago Jamiltepec, a small indigenous community from Oaxaca State, Mexico. This population has shown a high prevalence of type 2 diabetes mellitus, and the aim of this study was to analyze the relationship between the Pst I (insulin gene), Nsi I (insulin receptor gene) and Gly972Arg (insulin receptor substrate 1 gene) polymorphisms and type 2 diabetes mellitus, obesity and hypertension in this population. Clinical evaluation consisted of BMI and blood pressure measurements, and biochemical assays consisted of determination of fasting plasma insulin and glucose levels. PCR and restriction enzyme digestion analysis were applied to genomic DNA to identify the three polymorphisms. From statistical analysis carried out here, individually, the Pst I, Nsi I and Gly972Arg polymorphisms were not associated with the type 2 diabetes, obese or hypertensive phenotypes in this population. Nevertheless, there was an association between the Nsi I and Pst I polymorphisms and increased serum insulin levels.
Flores-Martínez
S E
SE
División de Medicina Molecular, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Sierra Mojada 800, Colonia Independencia, C.P. 44340 Guadalajara, Jalisco, México. sefloresm@yahoo.com <sefloresm@yahoo.com>
Islas-Andrade
S
S
Machorro-Lazo
M V
MV
Revilla
M C
MC
Juárez
R E
RE
Mújica-López
K I
KI
Morán-Moguel
M C
MC
López-Cardona
M G
MG
Sánchez-Corona
J
J
D000328:Adult; D015703:Antigens, CD; D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D004247:DNA / Q000235:genetics; D015252:Deoxyribonucleases, Type II Site-Specific; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000453:epidemiology / Q000235:genetics*; D005006:Ethnicity; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D006973:Hypertension / Q000235:genetics*; D007328:Insulin / Q000097:blood / Q000235:genetics; D055504:Insulin Receptor Substrate Proteins; D008297:Male; D008800:Mexico / Q000453:epidemiology / Q000208:ethnology; D009765:Obesity / Q000235:genetics*; D010750:Phosphoproteins / Q000235:genetics; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D015995:Prevalence; D011972:Receptor, Insulin / Q000235:genetics
D015703:Antigens, CD; D001786:Blood Glucose; C526292:IRS1 protein, human; D007328:Insulin; D055504:Insulin Receptor Substrate Proteins; D010750:Phosphoproteins; D004247:DNA; C435941:INSR protein, human; D011972:Receptor, Insulin; C048503:ATGCAT-specific type II deoxyribonucleases; C024388:CTGCAG-specific type II deoxyribonucleases; D015252:Deoxyribonucleases, Type II Site-Specific